Pacific Biosciences of California (PACB) earnings, Nov 4, 2026: EPS +8%, stock −4.7%
In brief
Pacific Biosciences of California reported on Nov 4, 2026. Earnings per share changed +8% year over year, 10.8% above the estimate; revenue +6%. The stock opened with a −12.2% gap and closed the day −4.7% (Nov 5, 2026). The stock is now 29.3% below its 52-week high, +26.6% over 12 months. Next report: Feb 18, 2027.
EPS vs estimate+10.8%
EPS, YoY+8%
Revenue, YoY+6%
Gap · day−12.2% · −4.7%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 5, 2026 | 0.0% | −9.7% |
| Nov 4, 2026 | −12.2% | −4.7% |
Next-quarter estimates, ratings and the PACB chart are in the terminal.
Open the terminalFAQ
When is Pacific Biosciences of California's next earnings report?
Feb 18, 2027. The date comes from daily data and is corrected if the company moves it.
How did Pacific Biosciences of California stock react to the report?
Opening gap −12.2%, day's result −4.7%.
Did Pacific Biosciences of California's earnings grow?
Earnings per share rose 8% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.